FDA Reports 2 More Contaminated NECC Drugs

The FDA has reported the presence of bacteria in two additional drugs manufactured and distributed from the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.


Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Contamination was found in three lots of injectable betamethasone and one lot of cardioplegia solution. So far, the federal government has not reported any infections linked to these lots and is not changing its recommendations for diagnosing and treating patients who have received NECC products.

Over the course of the last several months, federal agencies have confirmed contaminated epidural steroid injections manufactured at NECC are linked to a meningitis outbreak that has injected hundreds of patients and killed 29.

More Articles on Patient Safety:

NQF Endorses Neurology, Behavioral Health Measures

5 Ways to Improve Outcomes for Neurosurgery Patients

Patient Safety Tool: Sample Fire Safety Plan

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Patient Safety Tools & Resources Database

Top 40 Articles from the Past 6 Months